Mirae Asset Global Investments’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$415K Sell
5,305
-1,528
-22% -$104K ﹤0.01% 1016
2026
Q1
$442K Buy
6,833
+1,119
+20% +$78.9K ﹤0.01% 956
2025
Q4
$385K Buy
5,714
+537
+10% +$36.1K ﹤0.01% 1041
2025
Q3
$380K Buy
5,177
+417
+9% +$27.7K ﹤0.01% 1029
2025
Q2
$248K Buy
4,760
+639
+16% +$36.4K ﹤0.01% 1023
2025
Q1
$263K Sell
4,121
-119
-3% -$6.91K ﹤0.01% 1007
2024
Q4
$204K Sell
4,240
-342
-7% -$17.5K ﹤0.01% 1046
2024
Q3
$261K Buy
4,582
+782
+21% +$44.8K ﹤0.01% 1044
2024
Q2
$196K Sell
3,800
-74,864
-95% -$3.28M ﹤0.01% 1049
2024
Q1
$2.92M Buy
78,664
+2,192
+3% +$82.2K 0.01% 1036
2023
Q4
$2.83M Buy
76,472
+674
+0.9% +$25.4K 0.01% 1107
2023
Q3
$2.9M Buy
75,798
+2,139
+3% +$87.6K 0.01% 1035
2023
Q2
$2.65M Sell
73,659
-4,130
-5% -$141K 0.01% 1082
2023
Q1
$2.97M Buy
77,789
+12,183
+19% +$571K 0.01% 1024
2022
Q4
$3.73M Buy
65,606
+77
+0.1% +$3.94K 0.01% 911
2022
Q3
$2.59M Buy
65,529
+16,246
+33% +$718K 0.01% 1032
2022
Q2
$2.17M Buy
+49,283
New +$2.13M 0.01% 1115
2021
Q4
Sell
-8,322
Closed -$339K 1649
2021
Q3
$339K Buy
8,322
+1,081
+15% +$45.2K ﹤0.01% 1584
2021
Q2
$329K Sell
7,241
-123
-2% -$5.44K ﹤0.01% 1560
2021
Q1
$307K Sell
7,364
-1,615
-18% -$73.7K ﹤0.01% 1410
2020
Q4
$384K Buy
8,979
+467
+5% +$16.8K ﹤0.01% 1389
2020
Q3
$224K Buy
+8,512
New +$237K ﹤0.01% 1405
2016
Q1
Sell
-101,492
Closed -$1.76M 489
2015
Q4
$1.76M Buy
101,492
+30,868
+44% +$492K 0.06% 247
2015
Q3
$949K Buy
70,624
+34,400
+95% +$691K 0.04% 297
2015
Q2
$818K Sell
36,224
-32,752
-47% -$576K 0.03% 336
2015
Q1
$985K Buy
+68,976
New +$995K 0.03% 301

Other funds holding HALO

Mirae Asset Global Investments's HALO Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Halozyme (HALO) stake by 22% in Q2 2026, selling an estimated $104K and leaving 5,305 shares worth $415K. The position accounts for ﹤0.01% of the portfolio, ranked #1016.

Mirae Asset Global Investments first reported a position in HALO in Q1 2015 and has held it in 26 quarters since. The position peaked at $3.73M in Q4 2022. 363 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Mirae Asset Global Investments held 5,305 shares of Halozyme worth $415K as of Q2 2026.
  • Mirae Asset Global Investments sold 1,528 Halozyme shares in Q2 2026, an estimated $104K.
  • Halozyme made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1016 holding.
  • Mirae Asset Global Investments first reported a position in Halozyme in Q1 2015 and has held it in 26 quarters since.
  • Mirae Asset Global Investments's Halozyme position peaked at $3.73M in Q4 2022.
  • 363 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.